Related Experiment Videos
Success in the treatment of hypertension: a status report
1Department of Geriatrics, University of Uppsala, Sweden.
Insights
Pharmacological interventions effectively reduce stroke and heart disease risks. Diuretics and beta-blockers are key in lowering blood pressure and improving patient outcomes in hypertension management.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Pharmacological interventions targeting elevated blood pressure significantly reduce stroke and coronary heart disease risks.
- Meta-analysis of 13 trials indicates diuretics and beta-adrenoceptor blocking agents are primary contributors to these benefits in hypertension.
Purpose of the Study:
- To review the established benefits of antihypertensive pharmacological treatments.
- To highlight ongoing research into newer agents and optimal blood pressure targets.
Main Methods:
- Review of meta-analysis of 13 large prospective intervention trials in hypertension.
- Examination of historical data from the 1950s-1960s on malignant hypertension treatment.
- Consideration of ongoing prospective trials with novel antihypertensive agents.
Main Results:
- Diuretics and beta-blockers have demonstrated significant positive effects on reducing cardiovascular morbidity and mortality.
- Early studies on malignant hypertension predated the widespread use of diuretics and beta-blockers.
Conclusions:
- Pharmacological treatment of hypertension, particularly with diuretics and beta-blockers, yields substantial benefits in reducing cardiovascular events.
- Further research is investigating newer drug classes and the optimal degree of blood pressure reduction for maximum therapeutic advantage.
Background:
Pharmacological intervention studies aimed at lowering elevated blood pressure have shown that stroke, and to a lesser degree coronary heart disease, morbidity and mortality are positively affected. These beneficial effects appear to have been obtained mainly with diuretics and beta-adrenoceptor blocking agents, as shown in a meta-analysis of 13 large prospective intervention trials in hypertension.
Previous Studies:
Benefits of pharmacological antihypertensive treatment were observed in the treatment of patients with malignant hypertension in the late 1950s and early 1960s. Many of these studies were conducted before diuretics became clinically available and long before the first reports of the antihypertensive effect of beta-blockers were published.
Prospective Studies:
Prospective intervention trials with newer antihypertensive agents such as calcium antagonists and angiotensin converting enzyme inhibitors are currently in progress. Three recently, open, retrospective case-control studies dealing with comparisons of various antihypertensive drug classes with regard to their effect on cardiovascular mortality have attracted interest.
Future Benefits:
Another question of considerable clinical importance is how far blood pressure should be lowered in order to extract the maximum benefit of treatment. This issue is currently being investigated.